BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6097444)

  • 1. Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF)-induced ACTH release in a patient with Nelson's syndrome.
    Hirata Y; Nakashima H; Uchihashi M; Tomita M; Fujita T; Ikeda M
    Endocrinol Jpn; 1984 Oct; 31(5):619-26. PubMed ID: 6097444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome.
    Mercado-Asis LB; Yanovski JA; Tracer HL; Chik CL; Cutler GB
    J Clin Endocrinol Metab; 1997 Feb; 82(2):514-7. PubMed ID: 9024246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
    Abraham RR; Campbell EA; Gillham B; Thody AJ; Altaher AR; Prysor-Jones A; Wynn V; Jones MT; Jenkins J
    Clin Endocrinol (Oxf); 1986 Jul; 25(1):75-85. PubMed ID: 3024873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
    Oosterom R; Verleun T; Uitterlinden P; Hackeng WH; Burbach JP; Wiegant VM; Lamberts SW
    Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
    Nakashima H; Hirata Y; Uchihashi M; Tomita M; Fujita T
    Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma ACTH levels and beta-endorphin-like immunoreactivity following administration of luteinizing hormone-releasing hormone in Nelson's syndrome.
    Kasperlik-Załuska AA; Abdel-Fattah MH; Jeske W; Puciłowska J
    Eur J Obstet Gynecol Reprod Biol; 1986 Apr; 21(4):199-205. PubMed ID: 3011530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyproheptadine treatment of Nelson's syndrome: restoration of plasma ACTH circadian periodicity and reversal of response to TRF.
    Krieger DT; Condon EM
    J Clin Endocrinol Metab; 1978 Feb; 46(2):349-52. PubMed ID: 220278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma beta-endorphin responses to somatostatin, thyrotropin-releasing hormone, or vasopressin in Nelson's syndrome.
    Oki S; Nakai Y; Nakao K; Imura H
    J Clin Endocrinol Metab; 1980 Jan; 50(1):194-7. PubMed ID: 6243130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
    Casulari LA; Naves LA; Mello PA; Pereira Neto A; Papadia C
    Horm Res; 2004; 62(6):300-5. PubMed ID: 15557761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unaltered stimulation of pituitary adrenocorticotrophin secretion by corticotrophin-releasing factor following sodium valproate administration in a patient with Nelson's syndrome.
    Gomi M; Iida S; Itoh Y; Moriwaki K; Kanayama S; Namba M; Tarui S
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):123-7. PubMed ID: 2996808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
    Jørgensen H; Skare S; Frey H; Hanssen KF; Norman N
    Acta Med Scand; 1985; 218(1):79-84. PubMed ID: 2996312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro.
    Chan JS; Gaspar L; Iguchi H; Seidah NG; Ling N; Chrétien M
    Clin Invest Med; 1984; 7(4):205-8. PubMed ID: 6335868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.
    Ishibashi M; Yamaji T
    J Clin Invest; 1981 Oct; 68(4):1018-27. PubMed ID: 6270192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained remission of Nelson's syndrome after stopping cyproheptadine treatment.
    Aronin N; Krieger DT
    N Engl J Med; 1980 Feb; 302(8):453-5. PubMed ID: 6243392
    [No Abstract]   [Full Text] [Related]  

  • 18. Probable ACTH-secreting pituitary tumour in association with Addison's disease.
    Yanase T; Sekiya K; Ando M; Nawata H; Kato K; Ibayashi H
    Acta Endocrinol (Copenh); 1985 Sep; 110(1):36-41. PubMed ID: 2994336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovine corticotrophin releasing factor stimulates ACTH release from human corticotrophinoma cells in culture; interaction with hydrocortisone and arginine vasopressin.
    White MC; Adams EF; Loizou M; Mashiter K; Fahlbusch R
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):295-302. PubMed ID: 3000651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.